ACBM (Acro Biomedical Co) 14-Day RSI: 100.00 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Acro Biomedical Co 14-Day RSI?

Acro Biomedical Co ACBM 14-Day RSI is 100.00 as of Jul. 15, 2026. The stock has 2 warning signs investors should review. Among 613 Diversified Financial Services companies, Acro Biomedical Co ranks worse than 99.51% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2026-07-15), Acro Biomedical Co's 14-Day RSI is 100.00.

The industry rank for Acro Biomedical Co's 14-Day RSI or its related term are showing as below:

ACBM's 14-Day RSI is ranked worse than
99.51% of 613 companies
in the Diversified Financial Services industry
Industry Median: 51.85 vs ACBM: 100.00

Acro Biomedical Co  (OTCPK:ACBM) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.

Acro Biomedical Co 14-Day RSI Related Terms

ACBM vs RNGC, EEGI, GMZP: 14-Day RSI Comparison

For the Shell Companies subindustry, Acro Biomedical Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acro Biomedical Co 14-Day RSI vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Acro Biomedical Co's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Acro Biomedical Co's 14-Day RSI falls into.


Acro Biomedical Co  (OTCPK:ACBM) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 14-Day RSI →
What does a 14-Day RSI of 100.00 mean?
Acro Biomedical Co (ACBM) has a 14-Day RSI of 100.00 as of Jul. 15, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Acro Biomedical Co and its competitors. According to the industry distribution chart, Acro Biomedical Co ranks #610 out of 613 companies in the Diversified Financial Services industry, placing it in the top 99.5%.
Is Acro Biomedical Co's 14-Day RSI too high?
Acro Biomedical Co's current 14-Day RSI is 100.00. The Diversified Financial Services industry median 14-Day RSI is 51.85. Acro Biomedical Co's value of 100.00 is 92.9% above this industry median. Based on the distribution chart, Acro Biomedical Co ranks #610 out of 613 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers.
How does Acro Biomedical Co's 14-Day RSI compare to RNGC and EEGI?
According to the Diversified Financial Services industry distribution chart, Acro Biomedical Co ranks #610 out of 613 companies for 14-Day RSI. This places Acro Biomedical Co in the lower half of its industry. The industry median 14-Day RSI is 51.85. Acro Biomedical Co's value of 100.00 is 92.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Diversified Financial Services company?
The median 14-Day RSI among Diversified Financial Services companies is 51.85, based on 613 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acro Biomedical Co's current 14-Day RSI of 100.00 is 92.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Acro Biomedical Co and its competitors. For the Diversified Financial Services industry, the median 14-Day RSI is 51.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acro Biomedical Co's current 14-Day RSI is 100.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acro Biomedical Co stock overvalued right now?
Acro Biomedical Co (ACBM) has a current 14-Day RSI of 100.00. The current 14-Day RSI is 100.00 and 92.9% above the Diversified Financial Services industry median of 51.85. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Acro Biomedical Co (ACBM), the current 14-Day RSI is 100.00 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acro Biomedical Co Business Description

Address 12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038
Acro Biomedical Co Ltd is a shell company.